ANN ARBOR, Mich. — Daicel Arbor Biosciences today announced the release of myReads Extractions, an in-house animal and plant DNA extraction service providing researchers with reliable, high-quality starting material for genomic sequencing and downstream analysis. Genomics research starts with extractions: the delicate process of removing genetic material from intact specimens. Despite the use of standard protocols […]
Company recognizes Musser for 39 years of dedicated service and lasting impact Board of Directors elects Hal Nelson chief operating officer, Lewis Steverson vice chairman, John Zhang chief corporate development officer Senior Leadership Team will help deliver company’s Springboard plan and advance long-term value creation and growth strategy CORNING, N.Y. — Corning Incorporated (NYSE: GLW) today announced that Eric […]
QIAcuity digital PCR kits, assays and protocols for lentivirus-based therapies support quality control in cell and gene therapy manufacturing Expansion underscores the commitment of QIAGEN to help accelerate the development of safe and effective biotherapeutics New solutions support high-precision analytics for process development, batch release and regulatory compliance and enable a standardized workflow VENLO, the […]
Platform integrates yeast-based synthetic biology and robotics to streamline antibody discovery, eliminating lengthy steps and significantly reducing costs compared to traditional CRO outsourcing LONG ISLAND CITY, N.Y. – Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, and Neochromosome, Inc., its subsidiary specializing in products unlocked through genome-scale […]
PROVIDENCE, R.I. — Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping technology, announces its achievement of ISO 9001:2015 certification. This internationally recognized standard demonstrates Nabsys’ dedication to maintaining a robust and effective quality management system. The ISO 9001:2015 certification underscores Nabsys’ ability to consistently deliver products and services that meet customer expectations and regulatory requirements. […]
FORT MYERS, Fla. and FREMONT, Calif. — NeoGenomics, Inc. (Nasdaq:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, and Ultima Genomics, Inc., a developer of a revolutionary ultra-high throughput next-generation sequencing (NGS) platform, today announced a collaboration to use Ultima’s UG 100™ sequencing platform and its ppmSeq™ technology to advance NeoGenomics’ ability to offer innovative clinical tests. […]
Quanterix Files Updated Investor Presentation Highlighting Compelling Benefits of Combination BILLERICA, Mass. and MARLBOROUGH, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences (NASDAQ: AKYA), The Spatial Biology Company®, today announced an amendment to the terms of their previously announced merger agreement. Under the amended terms, Quanterix will issue approximately 7.76 […]
Launched with 300 million cells and growing, Arc’s collection of computation-ready, single-cell measurements is getting a boost from 10x and Ultima technologies Arc Institute continues its work to generate and share large-scale, high-quality datasets of cell state before and after chemical or genetic perturbations to enable “virtual cell” models and other innovations. Two months after […]
SAN DIEGO — CS Genetics, a leader in single cell genomics, is proud to announce the appointment of Paul McEwan as an Independent Director to its Board. Mr. McEwan brings over two decades of experience in life science tools, genomics, and strategic growth. Mr. McEwan is a serial entrepreneur in the life sciences sector, with a proven track […]
BOSTON — Volta Labs, Inc. today announced the launch of the Volta Access Program, a new initiative aimed at increasing access to its Callisto™ Sample Prep System for academic research institutions in the U.S. facing tightening capital budgets. Selected applicants will be able to access Callisto for $4,950 per month over a 24-month term, with full service support and no […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
